BACKGROUND: Chronic obstructive pulmonary disease (COPD) affects millions worldwide.
Despite advances in the treatments of other chronic diseases, little progress in decreasing …

Background Inhaled corticosteroids (ICS) have been shown to decrease the occurrence of
COPD exacerbations. However, the relationship of baseline lung function and reduction of …

In the treatment of asthma and chronic obstructive pulmonary disease (COPD), errors in
handling and wrong techniques in using inhalation devices are associated with poor …

Many flavonoids were demonstrated to posses the antiallergic effect. Here we detected
whether apigenin, a flavonoid, can attenuate allergen-induced airway inflammation and …

The COVID-19 pandemic has brought a renewed focus on appropriate management of
chronic respiratory conditions with a heightened awareness of respiratory symptoms and the …

Key Points Asthma is a heterogeneous syndrome ranging from mild disease with barely
noticeable symptoms to very severe disease with constant symptoms that may greatly hinder …

BACKGROUND: Use of inhalers requires accurate completion of multiple steps to ensure
effective medication delivery. OBJECTIVE: To evaluate the most problematic steps in the use …

Inhalation of bacterial endotoxin induces pulmonary inflammation by activation of nuclear
factor κB (NFκB), production of cytokines and chemokines, and neutrophil activation …

Asthma is a chronic inflammatory disorder of the airway. It is characterized by airway hyper-
reactivity, which can be attributed to the chronically inflamed airway. However, the molecular …

OBJECTIVE: To describe and characterize local adverse effects (in the oral cavity, pharynx,
and larynx) associated with the use of inhaled corticosteroids (ICSs) in patients with …